AU6400094A - Taxol polyalkylene oxide conjugates of taxol and taxol intermediates - Google Patents

Taxol polyalkylene oxide conjugates of taxol and taxol intermediates

Info

Publication number
AU6400094A
AU6400094A AU64000/94A AU6400094A AU6400094A AU 6400094 A AU6400094 A AU 6400094A AU 64000/94 A AU64000/94 A AU 64000/94A AU 6400094 A AU6400094 A AU 6400094A AU 6400094 A AU6400094 A AU 6400094A
Authority
AU
Australia
Prior art keywords
taxol
intermediates
polyalkylene oxide
oxide conjugates
conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64000/94A
Inventor
Durgadas Bolikal
Richard B Greenwald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enzon Pharmaceuticals Inc
Original Assignee
Enzon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzon Inc filed Critical Enzon Inc
Publication of AU6400094A publication Critical patent/AU6400094A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
AU64000/94A 1993-03-09 1994-03-09 Taxol polyalkylene oxide conjugates of taxol and taxol intermediates Abandoned AU6400094A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2838193A 1993-03-09 1993-03-09
US028381 1993-03-09
PCT/US1994/002530 WO1994020453A1 (en) 1993-03-09 1994-03-09 Taxol polyalkylene oxide conjugates of taxol and taxol intermediates

Publications (1)

Publication Number Publication Date
AU6400094A true AU6400094A (en) 1994-09-26

Family

ID=21843138

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64000/94A Abandoned AU6400094A (en) 1993-03-09 1994-03-09 Taxol polyalkylene oxide conjugates of taxol and taxol intermediates

Country Status (2)

Country Link
AU (1) AU6400094A (en)
WO (1) WO1994020453A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0727992A4 (en) * 1993-10-20 2001-01-31 Enzon Inc 2'- and/or 7- substituted taxoids
US5730990A (en) * 1994-06-24 1998-03-24 Enzon, Inc. Non-antigenic amine derived polymers and polymer conjugates
KR100561788B1 (en) * 1996-03-12 2006-09-20 피지-티엑스엘 컴파니,엘.피. Compositions comprising water-soluble paclitaxel prodrugs and implantable medical devices comprising such compositions
US6541508B2 (en) 1999-09-13 2003-04-01 Nobex Corporation Taxane prodrugs
US6380405B1 (en) * 1999-09-13 2002-04-30 Nobex Corporation Taxane prodrugs
US6713454B1 (en) 1999-09-13 2004-03-30 Nobex Corporation Prodrugs of etoposide and etoposide analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante TAXOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides

Also Published As

Publication number Publication date
WO1994020453A1 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
AU6099694A (en) Azlactone activated polyalkylene oxides
AU6833994A (en) Incorporation of taxol into liposomes and gels
AU7571696A (en) Oxide materials and catalyst compositions containing them
SG75800A1 (en) Multimetal oxide materials
AU6452394A (en) UV-absorbing polyurethanes and polyesters
DE59400838D1 (en) Multimetal oxide materials
AU4165993A (en) Aminediol compounds and derivatives and halohydrin intermediates
AU5752398A (en) Novel ketobenzamides and their use
AU5494294A (en) Hop extract and use thereof
AU3794895A (en) Alkylene oxide production
AU9334998A (en) Processing and use of carbide lime
AU6473594A (en) Disposable undergarment
AU6120994A (en) Anticonvulsive agents and uses thereof
AU6711994A (en) Rapamycin conjugates and antibodies
AU3470793A (en) Bioreduction of metal oxides and oxyanions by photosynthetic bacteria
AU6438094A (en) Coumarin derivative and use thereof
AU6899994A (en) Novel macrolides and the use thereof
AU6400094A (en) Taxol polyalkylene oxide conjugates of taxol and taxol intermediates
AU1538497A (en) Anti-gp46 antibodies and fragments thereof and their use
AU3674595A (en) Antianemic agent containing iron and difructose
AU7019794A (en) Oligomer conjugates and their use
AU2438695A (en) Therapeutic phenoxyalkylpyridazines and intermediates therefor
AU6723294A (en) Use of simmondsine
AU6472694A (en) Disposable undergarment
AU6933694A (en) Refractory oxides